Amit Gupta Sells 15,160 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CEO Amit Gupta sold 15,160 shares of the stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $3.92, for a total value of $59,427.20. Following the completion of the sale, the chief executive officer now owns 215,494 shares in the company, valued at approximately $844,736.48. The trade was a 6.57 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Amit Gupta also recently made the following trade(s):

  • On Friday, January 3rd, Amit Gupta sold 5,964 shares of Cardlytics stock. The shares were sold at an average price of $3.67, for a total value of $21,887.88.

Cardlytics Stock Up 1.3 %

Shares of Cardlytics stock opened at $3.88 on Friday. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. The stock has a market cap of $197.19 million, a price-to-earnings ratio of -0.64 and a beta of 1.53. The firm’s 50-day moving average is $3.66 and its two-hundred day moving average is $4.36. Cardlytics, Inc. has a 1 year low of $2.76 and a 1 year high of $20.52.

Cardlytics (NASDAQ:CDLXGet Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.18. The firm had revenue of $67.06 million for the quarter, compared to the consensus estimate of $57.77 million. Cardlytics had a negative net margin of 93.55% and a negative return on equity of 110.67%. The company’s quarterly revenue was down 15.1% on a year-over-year basis. During the same period last year, the firm earned ($0.26) earnings per share. As a group, research analysts expect that Cardlytics, Inc. will post -1.52 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in CDLX. Tallon Kerry Patrick bought a new position in Cardlytics in the fourth quarter worth about $37,000. Atom Investors LP purchased a new position in shares of Cardlytics in the 3rd quarter worth approximately $33,000. XTX Topco Ltd bought a new position in shares of Cardlytics during the 2nd quarter worth approximately $107,000. SG Americas Securities LLC purchased a new stake in Cardlytics during the third quarter valued at approximately $45,000. Finally, Intech Investment Management LLC acquired a new stake in Cardlytics in the third quarter valued at approximately $47,000. 68.10% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on CDLX shares. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, November 6th. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research report on Friday, January 17th. Finally, Evercore ISI assumed coverage on shares of Cardlytics in a research report on Friday, October 11th. They set an “in-line” rating and a $4.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Cardlytics currently has an average rating of “Hold” and a consensus price target of $6.92.

Read Our Latest Stock Analysis on Cardlytics

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Articles

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.